310 related articles for article (PubMed ID: 1345571)
1. A correlative study between cortisol and ACTH in Cushing's disease following bilateral adrenalectomy and in Nelson's syndrome.
Kasperlik-Załuska A; Niegowska E; Migdalska B; Jeske W; Zieliński M
Endokrynol Pol; 1992; 43(3):314-21. PubMed ID: 1345571
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH.
Oldfield EH; Schulte HM; Chrousos GP; Gold PW; Benker G; Peterson RE; Cutler GB; Loriaux DL
J Clin Endocrinol Metab; 1986 May; 62(5):1020-6. PubMed ID: 3007552
[TBL] [Abstract][Full Text] [Related]
3. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
[TBL] [Abstract][Full Text] [Related]
4. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
Krieger DT; Luria M
J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
[TBL] [Abstract][Full Text] [Related]
5. [Is it possible to predict the development of Nelson's syndrome in Cushing's disease after bilateral adrenalectomy?].
Horký K; Kanka J; Gregorová I; Tomsová Z; Dvoráková J
Cas Lek Cesk; 1990 May; 129(21):645-9. PubMed ID: 2164450
[TBL] [Abstract][Full Text] [Related]
6. Patient's age is a simple predictive factor for the development of Nelson's syndrome after total adrenalectomy for Cushing's disease.
Kemink L; Pieters G; Hermus A; Smals A; Kloppenborg P
J Clin Endocrinol Metab; 1994 Sep; 79(3):887-9. PubMed ID: 8077377
[TBL] [Abstract][Full Text] [Related]
7. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
Yamaji T; Ishibashi M; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
[TBL] [Abstract][Full Text] [Related]
8. A study of patients with Nelson's syndrome.
Pereira MA; Halpern A; Salgado LR; Mendonça BB; Nery M; Liberman B; Streeten DH; Wajchenberg BL
Clin Endocrinol (Oxf); 1998 Oct; 49(4):533-9. PubMed ID: 9876353
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Nelson's syndrome and residual adrenocortical function in patients of Cushing's disease after bilateral adrenalectomy.
Misra D; Kapur MM; Gupta DK
J Assoc Physicians India; 1994 Apr; 42(4):304-5. PubMed ID: 7860549
[TBL] [Abstract][Full Text] [Related]
10. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and cushing's disease.
Elias AN; Gwinup G; Valenta LJ
Clin Endocrinol (Oxf); 1981 Aug; 15(2):151-4. PubMed ID: 6273025
[TBL] [Abstract][Full Text] [Related]
11. The effect of sodium valproate on plasma ACTH and cortisol concentrations in Cushing's disease and Nelson's syndrome.
Kasperlik-Załuska A; Drac-Kaniewska J; Migdalska B; Jeske W; Wiśniewska-Woźniak T
Endokrynol Pol; 1988; 39(5):245-52. PubMed ID: 2855625
[No Abstract] [Full Text] [Related]
12. Management of Nelson's syndrome: observations in fifteen patients.
Kemink SA; Grotenhuis JA; De Vries J; Pieters GF; Hermus AR; Smals AG
Clin Endocrinol (Oxf); 2001 Jan; 54(1):45-52. PubMed ID: 11167925
[TBL] [Abstract][Full Text] [Related]
13. Lack of ACTH lowering effect of sodium valproate in patients with ACTH hypersecretion.
Loli P; Berselli ME; Frascatani F; Muratori F; Tagliaferri M
J Endocrinol Invest; 1984 Apr; 7(2):93-6. PubMed ID: 6327800
[TBL] [Abstract][Full Text] [Related]
14. Electron microscopical morphometry of well-differentiated and undifferentiated ACTH secreting adenomas in Cushing's disease and Nelson's syndrome.
Reuss WA; Saeger W; Lüdecke DK
Virchows Arch A Pathol Anat Histopathol; 1991; 419(5):395-401. PubMed ID: 1661044
[TBL] [Abstract][Full Text] [Related]
15. Nelson's syndrome -- 46 years later: clinical experience with 37 patients.
Kasperlik-Załuska AA; Bonicki W; Jeske W; Janik J; Zgliczyński W; Czernicki Z
Zentralbl Neurochir; 2006 Feb; 67(1):14-20. PubMed ID: 16518746
[TBL] [Abstract][Full Text] [Related]
16. ACTH responses to somatostatin, valproic acid and dexamethasone in Nelson's syndrome.
Kasperlik-Załuska AA; Zgliczyński W; Jeske W; Zdunowski P
Neuro Endocrinol Lett; 2005 Dec; 26(6):709-12. PubMed ID: 16380696
[TBL] [Abstract][Full Text] [Related]
17. Early diagnosis of Nelson's syndrome.
Kasperlik-Zaluska AA; Walecki J; Jeske W; Migdalska B; Janik J; Bonicki W; Brzeziński J; Makowska A; Brzezińska A
J Mol Neurosci; 1996; 7(2):87-90. PubMed ID: 8873892
[TBL] [Abstract][Full Text] [Related]
18. The effect of sodium valproate in Cushing's disease, Nelson's syndrome and Addison's disease.
Reincke M; Allolio B; Kaulen D; Jaursch-Hancke C; Winkelmann W
Klin Wochenschr; 1988 Aug; 66(15):686-9. PubMed ID: 2845188
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal evaluation of adrenocorticotrophin and beta-lipotrophin plasma levels following bilateral adrenalectomy in patients with Cushing's disease.
Moreira AC; Castro M; Machado HR
Clin Endocrinol (Oxf); 1993 Jul; 39(1):91-6. PubMed ID: 8394230
[TBL] [Abstract][Full Text] [Related]
20. Nelson's syndrome: incidence and prognosis.
Kasperlik-Załuska AA; Nielubowicz J; Wisławski J; Hartwig W; Załuska J; Jeske W; Migdalska B
Clin Endocrinol (Oxf); 1983 Dec; 19(6):693-8. PubMed ID: 6317234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
